Bavarian Nordic (OTCMKTS:BVNRY) Trading Down 6.9% – Here’s What Happened

Bavarian Nordic (OTCMKTS:BVNRY) shares traded down 6.9% during mid-day trading on Friday . The company traded as low as $8.99 and last traded at $8.99. 3,931 shares were traded during mid-day trading, a decline of 41% from the average session volume of 6,698 shares. The stock had previously closed at $9.66.

Bavarian Nordic Stock Performance

The business has a 50 day simple moving average of $11.79 and a 200-day simple moving average of $10.63. The firm has a market capitalization of $2.16 billion, a price-to-earnings ratio of 10.45 and a beta of 1.23.

Bavarian Nordic (OTCMKTS:BVNRY) last announced its quarterly earnings data on Friday, November 14th. The company reported $0.72 earnings per share (EPS) for the quarter. Bavarian Nordic had a net margin of 21.95% and a return on equity of 12.35%. The firm had revenue of $281.11 million during the quarter. Equities analysts predict that Bavarian Nordic will post 0.67 earnings per share for the current fiscal year.

About Bavarian Nordic

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.